Font Size: a A A
Keyword [RRCL]
Result: 1 - 2 | Page: 1 of 1
1. The Anticancer Activity Of Histone Deacetylase Inhibitor(IBH589) In Rituximab-resistant Raji Cell
2. Acquired rituximab resistance is associated with cross -resistance to chemotherapy that is overcome by treatment with bortezomib
  <<First  <Prev  Next>  Last>>  Jump to